REYON Pharmaceutical Co., Ltd.

KOSE:A102460 株式レポート

時価総額：₩246.3b

このページの翻訳は実験的なもので、現在開発中です。お待ちしております！

REYON Pharmaceutical マネジメント

マネジメント 基準チェック /04

現在、CEO に関する十分な情報がありません。

主要情報

Soon-Ock Jung

最高経営責任者

n/a

報酬総額

CEO給与比率n/a
CEO在任期間no data
CEOの所有権17.1%
経営陣の平均在職期間データなし
取締役会の平均在任期間データなし

経営陣の近況

Recent updates

There May Be Reason For Hope In REYON Pharmaceutical's (KRX:102460) Disappointing Earnings

Mar 31
There May Be Reason For Hope In REYON Pharmaceutical's (KRX:102460) Disappointing Earnings

Consider This Before Buying REYON Pharmaceutical Co., Ltd. (KRX:102460) For The 1.6% Dividend

May 08
Consider This Before Buying REYON Pharmaceutical Co., Ltd. (KRX:102460) For The 1.6% Dividend

Here's Why REYON Pharmaceutical (KRX:102460) Has A Meaningful Debt Burden

Apr 09
Here's Why REYON Pharmaceutical (KRX:102460) Has A Meaningful Debt Burden

What Percentage Of REYON Pharmaceutical Co., Ltd. (KRX:102460) Shares Do Insiders Own?

Feb 28
What Percentage Of REYON Pharmaceutical Co., Ltd. (KRX:102460) Shares Do Insiders Own?

Read This Before Buying REYON Pharmaceutical Co., Ltd. (KRX:102460) For Its Dividend

Jan 20
Read This Before Buying REYON Pharmaceutical Co., Ltd. (KRX:102460) For Its Dividend

REYON Pharmaceutical (KRX:102460) Seems To Use Debt Quite Sensibly

Jan 02
REYON Pharmaceutical (KRX:102460) Seems To Use Debt Quite Sensibly

Did REYON Pharmaceutical's (KRX:102460) Share Price Deserve to Gain 50%?

Dec 12
Did REYON Pharmaceutical's (KRX:102460) Share Price Deserve to Gain 50%?

How Much Of REYON Pharmaceutical Co., Ltd. (KRX:102460) Do Insiders Own?

Nov 24
How Much Of REYON Pharmaceutical Co., Ltd. (KRX:102460) Do Insiders Own?

CEO（最高経営責任者

Soon-Ock Jung (74 yo)

no data

在職期間

Ms. Soon-Ock Jung serves as a Chairman and Chief Executive Officer of REYON Pharmaceutical Co., Ltd. She served as a Managing Director of REYON Pharmaceutical Co., Ltd.